Protease inhibitor boosting is complex, requires thorough knowledge of interactions.
Monier
Paul
P
Infectious Diseases, LSU Health Sciences Center, Louisiana, USA.
D016903:Drug Monitoring; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D016879:Salvage Therapy
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors